AstraZeneca, Rachel Reeves

AstraZeneca ditches UK investment over cut in state support
AstraZeneca on Friday scrapped plans to invest 450 million pounds ($558.3 million) in its vaccine manufacturing plant in northern England, citing a cut in British government support.
Blow for Reeves as AstraZeneca ditches £450m investment
AstraZeneca has scrapped plans to invest £450m in expanding a vaccine manufacturing plant in Merseyside, blaming a reduction in government support. The pharmaceutical giant announced its decision just two days after Chancellor Rachel Reeves set out Labour's plan to go "further and faster" to boost economic growth.
AstraZeneca abandons £450m vaccine factory in blow to Reeves
AstraZeneca has abandoned a £450m investment in a major UK vaccine plant just days after Rachel Reeves vowed to “kick-start economic growth...
AstraZeneca scraps plan to expand vaccine plant in the UK in blow to government
Pharmaceutical company AstraZeneca has cancelled a planned 450 million-pound investment in a vaccine manufacturing plant in northwest England.
AstraZeneca ditches UK investment over cut in government support
AstraZeneca will no longer invest 450 million pounds ($558.3 million) at its vaccine manufacturing plant in northern England, the company said on Friday, citing a reduction in government support. The
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant
Fresh blow for Rachel Reeves as AstraZeneca scraps £450m investment in UK vaccine plant - The pharmaceutical giant claimed the Labour Government failed to match its predecessor’s offer
AstraZeneca Stock Rally Will be Tested by Answers on China Probe
A revival in AstraZeneca Plc shares faces a key test this week, with more likely to hinge on the drugmaker’s ability to ...
Medscape6h
AstraZeneca Sues Generic Drugmakers, Claims Cancer Drug Patent Violations
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
AstraZeneca’s Imfinzi recommended for approval in EU by CHMP
Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...
'AstraZeneca ditches vaccine plant' and Trump's EU tariff threat
The Financial Times leads on AstraZeneca's decision to scrap plans for a new vaccine manufacturing plant in Liverpool, ...
AstraZeneca rejected close to £80mn in state support for cancelled Speke factory
UK’s most valuable listed company raised NHS rejection of its new breast cancer drug and the drug pricing mechanism during negotiations ...
AstraZeneca: CHMP Recommends Approval Of Imfinzi In The EU
AstraZeneca (AZN.L, AZN) announced Imfinzi was recommended for approval in the European Union by CHMP as first and only immunotherapy ...
Mayor wants to continue talks with AstraZeneca
Metro Mayor Steve Rotheram has said he is hoping to restart talks with AstraZeneca after it scrapped plans to invest £450m in ...
New Vision on MSN1d
AstraZeneca cancels UK plant after subsidies cut
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million ...